Literature DB >> 32954465

Lymph Node Ratio Is an Independent Prognostic Factor for Patients with Siewert Type II Adenocarcinoma of Esophagogastric Junction: Results from a 10-Year Follow-up Study.

Yuling Zhang1, Ditian Liu2, Chunfa Chen3.   

Abstract

PURPOSE: Emerging evidences suggest that lymph node ratio (LNR), the number of metastatic lymph node (LN) to the total number of dissected lymph nodes (NDLN), may predict survival in multiple types of solid tumor. However, the prognostic role of LNR in adenocarcinoma of the esophagogastric junction (AEG) remains uninvestigated. The present study is intended to determine the prognostic value of LNR in the patients with Siewert type II AEG.
METHODS: A total of 342 patients with Siewert type II AEG who underwent R0 resection were enrolled in this study. The optimal cutoff of LNR was stratified into tertiles using X-tile software. The log-rank test was used to evaluate the survival differences, and multivariate Cox regression analyses were performed to determine the independent prognostic variables.
RESULTS: The optimal cutoff of LNR were classified as LNR = 0, LNR between 0.01 and 0.40, and LNR > 0.41. Patients with high LNR had a shorter 5- and 10-year disease-specific survival (DSS) rate (8.5%, 1.4%) compared with those with moderate LNR (20.4%, 4.9%) and low LNR (58.0%, 27.5%) (P < 0.001). Multivariate Cox regression analysis indicated that LNR was an independent factor for DSS after adjusting for confounding variables (P < 0.05). Furthermore, after stratification by NDLN between NDLN < 15 group and NDLN ≥ 15 group, the LNR remained a significant predictor for DSS (P < 0.05).
CONCLUSIONS: LNR is an independent predictor for DSS in patients with Siewert type II AEG regardless of NDLN. Patients with higher LNR have significantly shorter DSS.
© 2020. Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Adenocarcinoma of the esophagogastric junction; Lymph node ratio; Number of dissected lymph nodes; Prognosis

Mesh:

Year:  2021        PMID: 32954465     DOI: 10.1007/s12029-020-00468-y

Source DB:  PubMed          Journal:  J Gastrointest Cancer


  27 in total

1.  Classification of adenocarcinoma of the oesophagogastric junction.

Authors:  J R Siewert; H J Stein
Journal:  Br J Surg       Date:  1998-11       Impact factor: 6.939

2.  Stage migration effect on survival in gastric cancer surgery with extended lymphadenectomy: the reappraisal of positive lymph node ratio as a proper N-staging.

Authors:  Seong-Ho Kong; Hyuk-Joon Lee; Hye Seong Ahn; Jong-Won Kim; Woo Ho Kim; Kuhn Uk Lee; Han-Kwang Yang
Journal:  Ann Surg       Date:  2012-01       Impact factor: 12.969

3.  Cancer of the gastric cardia is rising in incidence in an Asian population and is associated with adverse outcome.

Authors:  Chris Deans; Matthew S W Yeo; Mu Yar Soe; Asim Shabbir; T K Ti; Jimmy B Y So
Journal:  World J Surg       Date:  2011-03       Impact factor: 3.352

4.  Comparison of three lymph node staging schemes for predicting outcome in patients with gastric cancer.

Authors:  X Wang; D-H Appleby; X Zhang; L Gan; J-J Wang; F Wan
Journal:  Br J Surg       Date:  2013-01-15       Impact factor: 6.939

5.  Log Odds of Positive Lymph Nodes Predicts Survival in Patients After Resection for Esophageal Cancer.

Authors:  Jinlin Cao; Ping Yuan; Honghai Ma; Peng Ye; Yiqing Wang; Xiaoshuai Yuan; Feichao Bao; Wang Lv; Jian Hu
Journal:  Ann Thorac Surg       Date:  2016-05-13       Impact factor: 4.330

6.  A rising trend of gastric cardia cancer in Gansu Province of China.

Authors:  Yongning Zhou; Zhiyi Zhang; Zhenkun Zhang; Jing Wu; Denxian Ren; Xiang Yan; Qing Wang; Yuling Wang; Huizheng Wang; Jun Zhang; Xiaoling Zhu; Yongchen Yang; Chong Luo; Xian Guo; Chengwei Tang; Liang Qiao
Journal:  Cancer Lett       Date:  2008-05-22       Impact factor: 8.679

7.  Prognostic influences of lymph node ratio in major cancers of Taiwan: a longitudinal study from a single cancer center.

Authors:  Yen-Lin Chen; Cheng-Yi Wang; Chin-Chia Wu; Moon-Sing Lee; Shih-Kai Hung; Wei-Chou Chen; Chih-Yao Hsu; Chia-Wen Hsu; Chih-Yuan Huang; Yu-Chieh Su; Ching-Chih Lee
Journal:  J Cancer Res Clin Oncol       Date:  2014-08-29       Impact factor: 4.553

8.  Retrospective review using targeted deep sequencing reveals mutational differences between gastroesophageal junction and gastric carcinomas.

Authors:  Hector H Li-Chang; Katayoon Kasaian; Ying Ng; Amy Lum; Esther Kong; Howard Lim; Steven Jm Jones; David G Huntsman; David F Schaeffer; Stephen Yip
Journal:  BMC Cancer       Date:  2015-02-06       Impact factor: 4.430

9.  Changes of Esophagogastric Junctional Adenocarcinoma and Gastroesophageal Reflux Disease Among Surgical Patients During 1988-2012: A Single-institution, High-volume Experience in China.

Authors:  Kai Liu; Kun Yang; Weihan Zhang; Xiaolong Chen; Xinzu Chen; Bo Zhang; Zhixin Chen; Jiaping Chen; Yongfan Zhao; Zongguang Zhou; Longqi Chen; Jiankun Hu
Journal:  Ann Surg       Date:  2016-01       Impact factor: 12.969

10.  Comparison on Clinicopathological Features and Prognosis Between Esophagogastric Junctional Adenocarcinoma (Siewert II/III Types) and Distal Gastric Adenocarcinoma: Retrospective Cohort Study, a Single Institution, High Volume Experience in China.

Authors:  Kai Liu; Weihan Zhang; Xiaolong Chen; Xinzu Chen; Kun Yang; Bo Zhang; Zhixin Chen; Zongguang Zhou; Jiankun Hu
Journal:  Medicine (Baltimore)       Date:  2015-08       Impact factor: 1.817

View more
  3 in total

1.  Novel Prognostic Models Predicting the Cancer-Specific Survival in Patients with Cutaneous Melanoma Based on Metastatic Lymph Node Status.

Authors:  Wei Li; Xuewen Xu; Yange Zhang
Journal:  Ann Surg Oncol       Date:  2021-01-11       Impact factor: 5.344

2.  Prognostic nomogram for Siewert type II adenocarcinoma of the esophagogastric junction patients with and without neoadjuvant radiotherapy: a retrospective cohort study.

Authors:  Zhenjiang Guo; Ning Wang; Fangzhen Liu; Qun Zhao
Journal:  Am J Transl Res       Date:  2022-01-15       Impact factor: 4.060

3.  Comparison of Four Lymph Node Staging Systems in Gastric Adenocarcinoma after Neoadjuvant Therapy - A Population-Based Study.

Authors:  Hongkun Lai; Jiabin Zheng; Yong Li
Journal:  Front Surg       Date:  2022-05-27
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.